|
|
Mechanisms of neurogenic bladder dysfunction in a viral murine model of multiple sclerosis |
| 1 R01 DK116648-01A1 |
MALYKHINA, ANNA P |
NIDDK |
2020 |
|
|
Gut-brain axis in Parkinsons disease |
| 1 R01 DK124098-01A1 |
SUBRAMANIAN, THYAGARAJAN |
NIDDK |
2020 |
|
|
Biomarkers and additive therapies to enhance symptomatic treatment of Spinal Muscular Atrophy |
| 5R01HD060586-09 |
BURGHES, ARTHUR H M |
NIDDK |
2020 |
|
|
The Impact of Diabetes on Revascularization in BEST-CLI |
| 5R01HL131977-05 |
BECKMAN, JOSHUA A |
NIDDK |
2020 |
|
|
The Gut Microbiome in Parkinson Disease |
| 5R01NS097723-05 |
PALACIOS, NATALIA MOROZOVA |
NIDDK |
2020 |
|
|
The gut brain axis: microbial impact on neural function |
| 5R01NS107475-03 |
ALKEMA, MARK |
NIDDK |
2020 |
|
|
Using single-cell approaches to study inflammatory bowel disease |
| 5R21DK119724-02 |
CHANG, JOHN T |
NIDDK |
2020 |
|
|
Alpha-synuclein aggregation disrupts motility, synaptic transmission, and calcium signaling in the myenteric plexus of the rat colon |
| 7R01DK108798-04 |
MANFREDSSON, FREDRIC |
NIDDK |
2020 |
